About Us

A world class team of founders, scientists, translational scientists, nutritionists, researchers, doctors, and advisors focused on a single mission: help people live a healthy, disease-free life.

Leadership Team

Naveen Jain

Founder & CEO

Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.

www.naveenjain.com

Guruduth Banavar

CTO & Head of Discovery AI

Guru is a leader in Artificial Intelligence known for his work on Host/Microbe Molecular Data Analysis, IBM Watson AI Systems, Smarter Cities, Services Innovation, Mobile Computing, and Distributed Systems. As founding CTO at Viome Life Sciences, he leads AI and co-leads clinical research.

Momo Vuyisich

Chief Science Officer

Momo brings more than 25 years of R&D experience in many scientific disciplines. He was most recently a scientist and leader of the Applied Genomics team at Los Alamos National Laboratory, where he successfully managed large national and international collaborations.

Emmanuel Hanon

Global Head of R&D

As global head of R&D for the vaccine group at GSK, Dr. Hanon oversaw teams across 50 countries dedicated to delivering discovery, development and management activities for the company's vaccine efforts. Dr. Hanon was responsible for the shared science and technology platforms supporting the entire vaccine business, managing technical development, clinical immunology, and preclinical stages of vaccine developments.

Stephen Barrie

VP & Head of Clinical Nutrition

Dr. Barrie is an internationally recognized physician, clinical medical researcher, lecturer, inventor, author, and entrepreneur, and one of the founding pioneers in the microbiome field. He is the founder and former CEO & Chairman of Genova Diagnostics, the world’s largest Functional Medicine clinical reference laboratory for physicians.

John Blanchard

Chief Operating Officer

John is an eCommerce and Operations leader who has spent the last 20+ years delivering customer-focused experiences on a global scale. He has a background in computer science, bioinformatics, marketing, supply chain, analytics, operations, and most recently held leadership roles at Amazon and Groupon.

Rodrigo Hutt

VP & GM of Consumer Group

Rodrigo is an entrepreneurial business leader with expertise in scaling emerging businesses, with over 17 years of experience in e-commerce, digital health, and biopharma. He was most recently Country Head, Marketplace VIS at Mercado Libre. Previously, Founder & CEO at VoyalDoc, BU Head Oncology at Pfizer, and Product Marketing at Merck.

Denis Sirringhaus

Head of BD, Viome Health Sciences

Denis has 20 years of experience in finance and biopharma. He was most recently Sr. Director of BD at Gossamer Bio. Previously, he was a Sr Commercial Assessment Leader for Roche/Genentech Partnering, building on his previous roles in product development, R&D Finance, and manufacturing.

Helene Vollbracht

Head of Communications

Helene joined in 2017 and oversaw Viome's early marketing and product efforts. She now oversees PR & Communications, translating the incredible power and capabilities of our technology into a story that inspires. Her background includes experience in the entertainment & music business, brand marketing, public relations, and behavioral science.

Scientific & Business Advisory Board

Stanley Lapidus

Stan Lapidus is an experienced life-science entrepreneur and inventor with over 30 issued U.S. patents. He founded SynapDX, a new company developing diagnostic tests for the early detection of autism, and currently serves as President and CEO. Prior to SynapDX, Stan founded and led Cytyc, EXACT Sciences and Helicos BioSciences, and holds academic appointments at Tufts and MIT.

Alessio Fasano

W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of Division of Pediatric Gastroenterology and Nutrition.

Andrew McCallum

Andrew McCallum is Professor and Director of the Information Extraction and Synthesis Laboratory, as well as Director of Center for Data Science in the College of Information and Computer Science at University of Massachusetts Amherst.

Emeran Mayer

Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry. Executive Director of G. Oppenheimer Center for Neurobiology of Stress and Resilience, and Co-director of CURE: Digestive Diseases Research Center.

Gilles J. Guillemin

Gilles J. Guillemin is the Co-funder of the MND and Neurodegenerative Diseases Research Centre, the Co-funder of the Macquarie University MND Biobank and the Head of the Neuroinflammation group at Macquarie University.

George Church

George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science.

Sanjiv Chopra

Sanjiv Chopra, MD, is a Professor of Medicine and served as Faculty Dean for Continuing Medical Education at Harvard Medical School for 12 years. He serves as a Marshall Wolf Master Clinician Educator Brigham and Women’s Hospital.

Ed Zuckerberg

Dr. Edward Zuckerberg has been a pioneer in the integration of technology in the dental office and development of techniques for delivering painless dentistry for over 30 years. He continues the advancement of newer dental technologies through lecturing at dental conferences and conventions.

Deepak Chopra

Described by TIME magazine as "one of the top 100 heroes and icons of the century", Deepak Chopra MD, FACP, is a world-renowned pioneer in integrative medicine. He is Board Certified in Internal Medicine, Endocrinology and Metabolism, a Fellow of the American College of Physicians, and a member of the American Association of Clinical Endocrinologists. He serves as a Clinical Professor of Medicine at the University of California, San Diego.

Vishen Lakhiani

Vishen Lakhiani is a Malaysian entrepreneur, author, and motivational speaker. He is the founder and CEO of Mindvalley and the author of The Code of the Extraordinary Mind and The Buddha and the Badass.

Board of Directors

Naveen Jain

Founder & CEO

Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.

www.naveenjain.com

Erik Anderson

Erik Anderson is a leader in global innovation recognized throughout his career for his business acumen and leadership. As the Founder and Chief Executive Officer of WestRiver Group (WRG), Anderson is redefining the paradigm of capital allocation with a transformative business model.

Chris Kitze

Chris Kitze is a technology innovator and investor. As a serial entrepreneur, he has created companies with over $7 billion of market capitalization during a 25-year career. He was part of the Lycos’ IPO team, and founder and CEO of Xoom.com (IPO: 1998), and was CEO of NBCi, formed by the merger of Xoom.com and Snap.com, in addition to other companies in digital communications, media and payments.

Bill Owens

Former Vice-Chairman of the Joint Chief of Staff of the United States of America, CEO of Nortel Telecommunications, Vice-Chairman for NYSE Asia, and Chairman and Senior Partner of AEA Investors Asia. Admiral Owens was also Chairman of Eastern Airlines and served on over 25 public boards including Daimler, British American Tobacco, Telstra, Nortel Networks, and Polycom.

Esteban Coppel

Esteban Coppel studied Environmental Economics and is interested in facilitating an improvement of the standard of living across the likes of the last 100 years, but in next 50 years. He is the largest investor in Biotech in Latin America with one of the earliest investments into mRNA technology. He also spearheads various investments in AI, Quantum Computing, Probiotics and Renewable Energy across the world. He is currently the chairman of 1200 an early stage VC fund of funds, and sits on various board from family offices, companies and VC funds.

Investors

“Viome is rapidly scaling to become a global leader in the longevity space, to promote better health outcomes today and our future generations, with exceptional innovation. The Viome team continues to accelerate leading AI-driven techniques to analyze gut microbiome data, which is leading to breakthrough new discoveries to help solve the root causes of so many chronic diseases to benefit all of mankind.”

Harish Consul, Founder & CEO, Ocgrow Ventures

“The future of healthcare is individual and personalized, and few companies have been driving innovation in this space as rapidly as Viome. Through the company’s continued research, development, and advancements within chronic disorders, cancers, and aging, Viome is bringing us one step closer to a world without chronic illness.”

Vinod Khosla, Founder & CEO of Khosla Ventures

"I am impressed by Viome’s unparalleled ability to produce high-quality insights from both the microbiome and human cells. This allows Viome to understand the underlying reasons for a range of chronic diseases and make food & supplement recommendations whose goal is to prevent and reverse these diseases."

Alessio Fasano, Professor and Director of the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital

"Viome is breaking new ground in developing precision recommendations of foods and supplements, and studying how these interventions can improve a range of chronic conditions, especially related to digestive and mood disorders. They are not only discovering the mechanisms underlying chronic diseases, but also developing new methods for improving the clinical outcomes using precision supplements interventions"

Emeran Mayer, Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry